K562

Conclusion: Tricholoma Matsutake is able to inhibit the proliferation and induce the differentiation of K562 cells.

Conclusion: The growth inhibition and apoptosis induction of K562 cells treated by DFMO were associated with suppressed telomerase activity.

Conclusion Etoposide chemotherapy combined with hyperthermia showed obvious inhibitive effect to K562 cells.

The K562 cells treated with toosendanin extracts showed morphological characteristics of apoptotic cells.

Result: Tricholoma Matsutake markedly inhibited K562 cell proliferation.

Objective: To investigate the effects of DFMO on the growth characteristics, apoptosis and activity of telomerase of K562 cells.

The cytotoxicity assays detected NK activity to K562 cells in patients with non secreting pituitary adenoma and healthy donor.

Objective To observe the effects of Triptolide on proliferation and apoptosis of erythroleukemia K562 in vitro.

K562 cells under iron deprivation was also confirmed by western blot analysis.

MTT method to observe the effects of different concentrations of serum and Rubus parvifolius saponin on K562 cell proliferation.

Methods The S1P receptors expression in K562 cells and CML patients'peripheral blood mononuclear cells was determined by RT-PCR assay.

K562 cells' cycle change induced by OD-PTD fusion protein was investigated by flow cytometry.

AIM: To explore how Glivec and HMBA affect the cell growth, apoptosis, cell cycle and cyclin protein expression of K562 cells.

Methods Human myeloid leukemia cells, K562 and NB4, were transduced by MDR retrovirus and the resistant cells were selected.

Results Nobiletin could significantly inhibit the proliferation of K562 and HL-60 cells in vitro.

Aim To observe the inhibitory effect of citrus extract Nobiletin on proliferation of leukemia K562 and HL-60 cells.

And some compounds were assayed for their anti-proliferation activity towards HL-60, K562 cell and SKOV3 cell. MTT method was employed.

But against leukemia cells (K562) activity more than the parent compound but less than VP-16;